Canopy Growth (CGC) Other Non Operating Income (2019 - 2025)
Canopy Growth's (CGC) quarterly Other Non Operating Income came in at -$25.7 million in Q4 2025, down 5075.25% year-on-year from $517558.9 in Q4 2024, and down 329.08% quarter-over-quarter from $11.2 million in Q3 2025.
Canopy Growth (CGC) Other Non Operating Income (2019 - 2025) Analysis & Trends
Canopy Growth has disclosed Other Non Operating Income across 7 years of filings, most recently posting -$25.7 million for Q4 2025.
- Other Non Operating Income for Q4 2025 came in at -$25.7 million, down 5075.25% year-over-year; the trailing twelve-month figure through Dec 2025 was $166.1 million (up 153.39% YoY), and the FY2025 annual result was $1.0 million, up 100.58% from the prior year.
- Other Non Operating Income came in at -$25.7 million for Q4 2025 at Canopy Growth, down from $11.2 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $472.4 million in Q2 2021 to a low of -$637.6 million in Q1 2022.
- The 5-year median for Other Non Operating Income is -$9.8 million (2025), against an average of -$31.6 million.
- Across the five-year window, Other Non Operating Income soared 11091.75% in 2021 and plunged 594935.41% in 2024, its largest moves.
- Canopy Growth's Other Non Operating Income stood at $27.2 million in 2021, then plunged by 412.83% to -$85.1 million in 2022, then slumped by 47.66% to -$125.6 million in 2023, then jumped by 100.41% to $517558.9 in 2024, then slumped by 5075.25% to -$25.7 million in 2025.
- The last three Other Non Operating Income figures came in at -$25.7 million (Q4 2025), $11.2 million (Q3 2025), and -$13.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Canopy Growth | 11.38 Mn | -137.31 Mn | 15.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -25.75 Mn |
| Sep 30, 2025 | 11.24 Mn |
| Jun 30, 2025 | -13.43 Mn |
| Mar 31, 2025 | 194.05 Mn |
| Dec 31, 2024 | 517,558.93 |
| Sep 30, 2024 | -62.53 Mn |
| Jun 30, 2024 | -68.65 Mn |
| Mar 31, 2024 | -180.46 Mn |
| Dec 31, 2023 | -125.63 Mn |
| Sep 30, 2023 | -95.73 Mn |
| Jun 30, 2023 | -103,478.89 |
| Mar 31, 2023 | -30,327.55 |
| Dec 31, 2022 | -85.08 Mn |
| Sep 30, 2022 | 1.47 Mn |
| Jun 30, 2022 | -192.62 Mn |
| Mar 31, 2022 | -637.62 Mn |
| Dec 31, 2021 | 27.20 Mn |
| Sep 30, 2021 | 155.56 Mn |
| Jun 30, 2021 | 472.39 Mn |
| Mar 31, 2021 | -6.10 Mn |